Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
This page is not indexed by search engines while we improve data quality.
Viroxis Sas — Human Necessities
Viroxis Sas holds 2 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Viroxis Sas |
| Technology | Human Necessities |
| Patents in slice | 2 |
| Recent patents in slice | 0 |
| First year | 2017 |
| Last year | 2018 |
Representative patents
Notable publications linking Viroxis Sas to Human Necessities.
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Recent filings
Latest patents from Viroxis Sas in Human Necessities.
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Mutated non-primate lentiviral Env proteins and their use as drugs
US-9974852-B2 · May 22, 2018 · US
Related pages
Navigate to parent entity pages.